Back

Nicotine reduces discrimination between threat and safety in the hippocampus, nucleus accumbens and amygdala

Mueller, M.; Fadai, T.; Rauh, J.; Haaker, J.

2023-05-08 pharmacology and therapeutics
10.1101/2023.05.08.23289647 medRxiv
Show abstract

Nicotine intake by cigarettes is linked to the maintenance and development of anxiety disorders and impairs adaptive discrimination of threat and safety in humans. Yet, it is unclear if nicotine exerts a causal pharmacological effect on the affective and neural mechanisms that underlie aversive learning. We conducted a pre-registered, pseudo-randomly and double-blinded pharmacological fMRI study to investigate the effect of acute nicotine on Fear Acquisition and Extinction in non-smokers (n=88). Our results show that nicotine administration led to decreased discrimination between threat and safety in subjective fear. Nicotine furthermore decreased differential (threat vs. safety) activation in the hippocampus, which was functionally coupled with Nucleus Accumbens and amygdala, compared to placebo controls. Additionally, nicotine led to overactivation of the ventral tegmental area. This study provides mechanistic evidence that single doses of nicotine impair neural substrates of adaptive aversive learning in line with the risk for the development of pathological anxiety.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Nicotine and Tobacco Research
13 papers in training set
Top 0.1%
25.5%
2
Neuropsychopharmacology
134 papers in training set
Top 0.1%
18.4%
3
European Neuropsychopharmacology
15 papers in training set
Top 0.1%
9.0%
50% of probability mass above
4
NeuroImage: Clinical
132 papers in training set
Top 0.5%
8.3%
5
Addiction Biology
47 papers in training set
Top 0.2%
7.1%
6
eLife
5422 papers in training set
Top 26%
3.5%
7
NeuroImage
813 papers in training set
Top 3%
3.5%
8
International Journal of Neuropsychopharmacology
11 papers in training set
Top 0.1%
2.7%
9
Nature Communications
4913 papers in training set
Top 49%
1.9%
10
Neuropharmacology
60 papers in training set
Top 0.4%
1.7%
11
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
1.2%
12
Scientific Reports
3102 papers in training set
Top 67%
1.2%
13
Psychological Medicine
74 papers in training set
Top 1%
1.1%
14
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.8%
0.9%
15
Translational Psychiatry
219 papers in training set
Top 4%
0.8%
16
Nicotine & Tobacco Research
11 papers in training set
Top 0.2%
0.8%
17
Journal of Psychopharmacology
14 papers in training set
Top 0.5%
0.8%
18
Psychopharmacology
59 papers in training set
Top 0.7%
0.7%
19
Frontiers in Pharmacology
100 papers in training set
Top 5%
0.7%
20
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 2%
0.7%
21
The Journal of Neuroscience
928 papers in training set
Top 9%
0.7%
22
The British Journal of Psychiatry
21 papers in training set
Top 1%
0.6%
23
The FASEB Journal
175 papers in training set
Top 4%
0.6%
24
Addiction Neuroscience
17 papers in training set
Top 0.5%
0.6%
25
Progress in Neurobiology
41 papers in training set
Top 3%
0.6%
26
Science Advances
1098 papers in training set
Top 33%
0.6%